Literature DB >> 18280446

Angiotensin-converting enzyme gene polymorphism is correlated to diabetic retinopathy: a meta-analysis.

Viroj Wiwanitkit1.   

Abstract

The angiotensin-converting enzyme (ACE) displays potent vasoconstrictive effects, attenuation of fibrinolysis, and platelet activation and aggregation. The ACE gene has been the main probable candidate gene predisposing the development of diabetic retinopathy (DR). However, the correlation between ACE gene polymorphism and progression of DR still requires further approval. Here, the author performs a summative analysis on recent previous reports on ACE gene polymorphism and its correlation to DR. The meta-analysis was performed in order to assess the correlation between the pattern of ACE gene polymorphism and DR. From four studies available, the author evaluated type II diabetic patients with (Group 1; n=432) and without DR (Group 2; n=329). The frequency of the DD genotype in Group 1 is not significantly different from that in Group 2 (P>.05). In addition, the author first reports a nonsignificant correlation between ethnicity and ACE gene polymorphism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280446     DOI: 10.1016/j.jdiacomp.2006.09.004

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

Review 1.  Does familial clustering of risk factors for long-term diabetic complications leave any place for genes that act independently?

Authors:  Andrew D Paterson; Shelley B Bull
Journal:  J Cardiovasc Transl Res       Date:  2012-06-23       Impact factor: 4.132

Review 2.  Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World.

Authors:  Ashay D Bhatwadekar; Aumer Shughoury; Ameya Belamkar; Thomas A Ciulla
Journal:  Genes (Basel)       Date:  2021-07-31       Impact factor: 4.141

3.  Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population.

Authors:  Shu Liang; Min Pan; Nan Hu; Yu-Yu Wu; Hui Chen; Jian-Hua Zhu; Huai-Jin Guan; Ai-Min Sang
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

4.  ACE polymorphism and diabetic nephropathy.

Authors:  V Wiwanitkit
Journal:  Indian J Nephrol       Date:  2010-04

5.  Multilocus genetic risk score for diabetic retinopathy in the Han Chinese population of Taiwan.

Authors:  Wen-Ling Liao; Jang-Ming Lin; Wen-Lu Chen; Ming-Chia Hsieh; Chia-Ming Wu; Ya-Wen Chang; Yu-Chuen Huang; Fuu-Jen Tsai
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

6.  A systematic meta-analysis of genetic association studies for diabetic retinopathy.

Authors:  Sotoodeh Abhary; Alex W Hewitt; Kathryn P Burdon; Jamie E Craig
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

7.  Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.

Authors:  Tengyue Zhang; Chong Pang; Ningdong Li; Elaine Zhou; Kanxing Zhao
Journal:  BMC Med       Date:  2013-01-02       Impact factor: 8.775

8.  The relationship between ACE/AGT gene polymorphisms and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes.

Authors:  Yong-Chao Qiao; Min Wang; Yan-Hong Pan; Xiao-Xi Zhang; Fang Tian; Yin-Ling Chen; Hai-Lu Zhao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Jan-Mar       Impact factor: 1.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.